Successful Biotech Licensing Negotiations

Biotech companies seeking to partner with their drug candidates should decide in advance what they want to achieve in deal negotiations. Getting the best outcome depends on non-financial, as well as financial terms. In this whitepaper, Linda Pullan provides licensing negotiation insights from a biotech business development perspective.

Prepare your team for the next deal by learning about:

  • Each step to the negotiation process
  • The Importance of establishing goals for the deal
  • Defining wants and needs for the deal
  • The basics of term sheets and common deal structures
  • Negotiating tips - how to prepare for negotiations, deal with disputes, and how to persuade


By supplying my contact information, I authorize ShareVault to contact me about relevant content, products, and services. We're committed to your privacy, for more information, check out our Privacy Policy.


Company team

Linda Pullan, PhD

Pullan Consulting

Linda offers biotech and
pharmaceutical companies consulting
in all aspects of partnering. Linda has
a Ph.D. in Biochemistry, a B.S. in
Chemistry, and more than twenty
years of drug industry
experience. Learn More

sharevault pricing or biopharma